Jennifer Knight

Jennifer Knight is a Senior Market Access Writer at Evidera, with a career spanning over 15 years in medical writing and research. Previous positions include Senior Medical Writer at Axiom, Medical Writer at IC Axon, and Research Associate at McGill University Goodman Cancer Research Centre, where significant projects included studying genomic events in triple negative breast cancer. Jennifer also served as a post-doctoral fellow at Susan G. Komen for the Cure, focusing on the MET receptor's role in cancer progression. Educationally, Jennifer holds a PhD from The Institute of Cancer Research and a BS in Medical Molecular Biology from the University of Wales, Cardiff.